Literature DB >> 21602779

In vitro and in vivo anticandidal activity of Swietenia mahogani methanolic seed extract.

G Sahgal1, S Ramanathan, S Sasidharan, M N Mordi, S Ismail, S M Mansor.   

Abstract

Swietenia mahogani crude methanolic (SMCM) seed extract was investigated for the antifungal activity against Candida albicans which has not been evaluated previously. The antifungal activity was evaluated against C. albicans via disk diffusion, minimum inhibition concentration (MIC), scanning electron microscope (SEM), transmission electron microscope (TEM) and time killing profile. The MIC value of SMCM seed extract is 12.5 mg/ml. The SEM and TEM findings showed there is morphological changes and cytological destruction of C. albicans at the MIC value. Animal model was used to evaluate the in vivo antifungal activity of SMCM seed extract. The colony forming unit (CFU) were calculated per gram of kidney sample and per ml of blood sample respectively for control, curative and ketaconazole treated groups. There was significant reduction for the CFU/ml of blood and CFU/g of kidney. This indicated that the extract was observed to be effective against C. albicans in vitro and in vivo conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602779

Source DB:  PubMed          Journal:  Trop Biomed        ISSN: 0127-5720            Impact factor:   0.623


  2 in total

Review 1.  In Vivo Anti-Candida Activity of Phenolic Extracts and Compounds: Future Perspectives Focusing on Effective Clinical Interventions.

Authors:  Natália Martins; Lillian Barros; Mariana Henriques; Sónia Silva; Isabel C F R Ferreira
Journal:  Biomed Res Int       Date:  2015-08-24       Impact factor: 3.411

Review 2.  Ageratum conyzoides L. and Its Secondary Metabolites in the Management of Different Fungal Pathogens.

Authors:  Rubal Chahal; Arun Nanda; Esra Küpeli Akkol; Eduardo Sobarzo-Sánchez; Ashwani Arya; Deepak Kaushik; Rohit Dutt; Rashmi Bhardwaj; Md Habibur Rahman; Vineet Mittal
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.